Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chris R. Franks"'
Autor:
Jens Atzpodien, Alfred Körfer, Klaus Resch, Pauline Evers, Martin Hadam, Ulrich Pohl, Harald Mohr, Hubert Poliwoda, Marta Szamel, Joseph Knüver-Hopf, Chris R. Franks, Hartmut Kirchner
Publikováno v:
Cancer. 67:1862-1864
Systemic administration of interleukin-2 (IL-2) in humans may induce antibodies specific to IL-2. The case is reported of a patient with metastatic rectal carcinoma who was treated with long-term subcutaneous IL-2 and a combination of subcutaneous IL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f74f397aa9f01606b5544e3f52fbbd84
https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co
https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co
Autor:
Klaus Hoeffken, Roland Mertelsmann, Chris R. Franks, Markus Boehm, Wolfgang Oster, Albrecht Lindemann, Volker Diehl, Joerg Hayungs, Otto Kloke, Reinhold E. Schmidt, Heinhold Gamm, Friedhelm Herrmann
Publikováno v:
Cancer Treatment Reviews. 16:53-57
The anti-tumor activity of high-dose recombinant interleukin-2 (IL-2) has been demonstrated in several recent preclinical and clinical studies. In an attempt to study possible synergistic effects with low-dose cyclophosphamide (CYC), a phase II clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dde49b98a9ae44d233c1de287ea541f
https://doi.org/10.1016/0305-7372(89)90023-6
https://doi.org/10.1016/0305-7372(89)90023-6
Autor:
H. Gamm, Otto Kloke, Chris R. Franks, Jonathan E. Kolitz, Markus Böhm, Klaus Höffken, Albrecht Lindemann, Roland Mertelsmann, Friedhelm Herrmann, Volker Diehl, Wolfgang Oster, Reinhold E. Schmidt, Jörg Hayungs
Publikováno v:
Cancer immunology, immunotherapy : CII. 28(4)
Recent preclinical and clinical studies that have demonstrated antitumor activity of high-dose recombinant interleukin-2 (rIL-2), and animal models that demonstrated a synergistic effect of low-dose cyclophosphamide, led us to study rIL-2 (Cetus Corp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7498a74cca40ee7d3eeffb171adefb3
https://pubmed.ncbi.nlm.nih.gov/2784715
https://pubmed.ncbi.nlm.nih.gov/2784715